Support for LAist comes from
We Explain L.A.
Stay Connected

Share This

This is an archival story that predates current editorial management.

This archival content was written, edited, and published prior to LAist's acquisition by its current owner, Southern California Public Radio ("SCPR"). Content, such as language choice and subject matter, in archival articles therefore may not align with SCPR's current editorial standards. To learn more about those standards and why we make this distinction, please click here.


Oh Nuts! Propecia Masks Prostate Cancer Tests

We need to hear from you.
Today during our spring member drive, put a dollar value on the trustworthy reporting you rely on all year long. The local news you read here every day is crafted for you, but right now, we need your help to keep it going. In these uncertain times, your support is even more important. We can't hold those in power accountable and uplift voices from the community without your partnership. Thank you.

A recent study has shown that the popular hair-loss drug Propecia can cockblock tests for prostate cancer.

In findings that were ironically funded by pharmaceutical giant Merck, the maker of Propecia, the drug that in some cases, can limit the natural disappearance of hair, can also limit the reliability of the commonly used prostate-specific antigen (PSA) test.

Men using Propecia "should be aware that their PSA will be falsely lowered" and that small changes upward could be signs of trouble, said study lead author Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston. - HealthDay News
Support for LAist comes from

Apparently 40% of the men studied between 40-49 had their PSA levels lowered after less than a year of taking Propecia, and 50% of men between 50-59 had lower PSAs. Meanwhile those men who took the placebo found their PSA rise on average of by Britt Elizabeth

Most Read